Tagaya M, Yamano K, Fukui T
Institute of Scientific and Industrial Research, Osaka University, Japan.
Biochemistry. 1989 May 30;28(11):4670-5. doi: 10.1021/bi00437a024.
Pyridoxal kinase from pig liver has been purified 10,000-fold to apparent homogeneity. The enzyme is a dimer of subunits of Mr 32,000. The enzyme is strongly inhibited by the product pyridoxal 5'-phosphate. Liver pyridoxamine phosphate oxidase, another enzyme involved in the biosynthesis of pyridoxal 5'-phosphate, is also strongly inhibited by this compound [Wada, H., & Snell, E. E. (1961) J. Biol. Chem. 236, 2089-2095]. Thus, the biosynthesis of pyridoxal 5'-phosphate in the liver might be regulated by the product inhibition of both pyridoxamine phosphate oxidase and pyridoxal kinase. Kinetic studies revealed that the catalytic reaction of liver pyridoxal kinase follows an ordered mechanism in which pyridoxal and ATP bind to the enzyme and ADP and pyridoxal 5'-phosphate are released from the enzyme, in this order. Adenosine tetraphosphopyridoxal was found to be a slow-binding inhibitor of pyridoxal kinase. Pre-steady-state kinetics of the inhibition revealed that the inhibitor and the enzyme form an initial weak complex prior to the formation of a tighter and slowly reversing complex. The overall inhibition constant was 2.4 microM. ATP markedly protects the enzyme against time-dependent inhibition by the inhibitor, whereas another substrate pyridoxal affords no protection. By contrast, adenosine triphosphopyridoxal is not a slow-binding inhibitor of this enzyme.
猪肝中的吡哆醛激酶已被纯化至表观均一,纯化倍数达10000倍。该酶是由分子量为32000的亚基组成的二聚体。该酶受到产物5'-磷酸吡哆醛的强烈抑制。肝脏中的磷酸吡哆胺氧化酶是另一种参与5'-磷酸吡哆醛生物合成的酶,也受到该化合物的强烈抑制[和田,H.,& 斯内尔,E. E.(1961年)《生物化学杂志》236,2089 - 2095]。因此,肝脏中5'-磷酸吡哆醛的生物合成可能受到磷酸吡哆胺氧化酶和吡哆醛激酶产物抑制的调节。动力学研究表明,肝脏吡哆醛激酶的催化反应遵循有序机制,即吡哆醛和ATP依次与酶结合,然后ADP和5'-磷酸吡哆醛依次从酶上释放。发现四磷酸腺苷吡哆醛是吡哆醛激酶的慢结合抑制剂。抑制作用的稳态前动力学表明,抑制剂与酶在形成更紧密且缓慢可逆的复合物之前先形成初始弱复合物。总体抑制常数为2.4微摩尔。ATP能显著保护该酶免受抑制剂的时间依赖性抑制,而另一种底物吡哆醛则无保护作用。相比之下,三磷酸腺苷吡哆醛不是该酶的慢结合抑制剂。